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Jesús Espada , Elisa Carrasco and María I. Calvo 
 
Summary 
In mammals, methylation of cytosine C-5 position is a major heritable epigenetic 
mark on the DNA molecule. Maintenance of proper DNA methylation patterns is a key 
process during embryo development and in the maintenance of adult tissue 
homeostasis. The use of experimental procedures based on the chemical modification 
of cytosine by sodium bisulfite and the development of antibodies recognizing 5mC 
have essentially contributed to our knowledge on DNA methylation dynamics in normal 
and disease states. Here we describe standard procedures for bisulfite sequencing, 
methylation-specific PCR and 5mC immunodetection using mouse skin and the hair 
follicle stem cell niche as model tissues. 
 
1. Introduction 
Methylation of the C-5 position of cytosine in CpG nucleotides is a major epigenetic 
mark in mammalian genomes implicated in key transcriptional regulation events during 
embryo development and in the maintenance of adult tissue homeostasis [1, 2]. 
Consequently, deregulation of DNA methylation patterns severely impairs cell and 
tissue viability and is associated to carcinogenesis [1-3]. At present, DNA methylation 
is considered the most stable and the only demonstrated as mitotically heritable 
epigenetic mark in mammals. However, the recent discovery that the methylated C-5 
position of cytosine can undergo further dynamical changes in the form of hydroxy-
methylation [4], that can act as an intermediate in CpG demethylation processes, adds 
additional complexity levels to the regulatory roles of DNA methylation in the cell.  
In a typical, non-transformed mammalian somatic cell, 5-methyl-cytosine (5mC) 
comprises a roughly 0.75-1% of all the nucleotides in the DNA molecule. Most of this 
5mC content  is found in CpG dinucleotides and 60-90% of CpG sites are methylated 
[1]. 5mC is largely concentrated in the repetitive fraction of the mammalian genome, 
expanding satellites α (alphoid DNA) and β (Sau3A family) in centromeric 
heterochromatin, LINES (LINE1 and 2 families), SINES (Alu and Mir families) and 
parasitic transposon and retroviral sequences [1]. An unsuspected high density of CpG 
dinucleotides, the so-called CpG islands, is present in the 5´ promoter region of about 
40% mammalian genes [5, 6]. A significantly elevated cytosine methylation ratio at 
these CpG islands has been causally associated to strong transcriptional repression [5, 
6]. Although a consistent methylation of CpG islands is consistently found only on 
imprinted genes and on a small proportion of non-imprinted genes, the maintenance of 
proper global CpG methylation patterns is thought to be essential in every step of 
development and in adult somatic tissues [5, 6]. 
The implementation of robust methodologies based on the chemical modification of 
non-methylated cytosines in the DNA molecule by sodium bisulfite treatment and 
subsequent conversion to uracil, including bisulfite sequencing [7] and methylation-
specific PCR [8] (Fig. 1), has enormously contributed to the improvement of 
biochemical DNA methylation analysis at a single-nucleotide resolution scale. These 
methodologies have also paved the way for the development of power techniques for 
large-scale, genome wide analysis of global changes in DNA methylation patterns 
during normal development or in disease states using Next Generation Sequencing 
(NGS) approaches [3, 9].  
Similarly, the generation of antibodies specifically recognizing 5mC [10] is a key 
landmark in the field allowing  a precise intranuclear compartment localization and 
quantification of this modified nucleotide  in cell culture and tissue samples [11, 12].  In 
the same way, these type of antibodies have foster the development of large-scale 
immunological methods for the immunoprecipitation of DNA methylated regions in the 
chromatin (methylated DNA immunoprecipitation; MeDIP) [13]. Immunoprecipitated 
DNA-methylated chromatin can further  constitute the start material for high-throughput,  
genome wide scale analysis using high-resolution DNA microarrays (MeDIP-chip) or 
NGS ( MeDIP-seq) [14]. 
As a straight consequence of the successful completion of several whole-genome 
sequencing projects in the last decade, we are witnessing to an unprecedented 
emergence of vast amounts of data related to chromatin dynamics and gene 
transcriptional regulation. In the context of DNA methylation, data obtained from 
different high-throughput experimental approaches at genome wide scales are of 
unquestionable analytical value, but require correct experimental validation to be 
interpreted in an adequate biological background. In this sense, standard methods for 
DNA methylation analysis not only are highly informative in different experimental 
situations but also are the methods of choice to validate high-throughput data. Here we 
describe standard procedures for bisulfite sequencing and 5mC immunolocalization 
using mouse skin and the hair follicle as biological models. 
 
2. Materials 
2.1. Isolation of epidermis from mouse tail skin.  
1. C57BL/6j mice. 
2. Sterile water. 
3. PBS, 5mM EDTA in PBS, 0.02 % sodium azide in PBS. 
4. Insulin type syringes, needles, sterile surgical scalpel blades, scissors and 
tweezers. 
2.2. DNA extraction, sodium bisulfite sequencing and methylation-specific PCR 
1. 3M NaOH (Merck). 
2. 3M NaC2H3O2 (sodium acetate, Merck). 
3. 10M AcNH4  (ammonium acetate, Merck). 
4. 10 mg/ml glycogen (Roche). 
5. Ethanol (Merck). 
6. Phenol/chloroform/isoamyl alcohol 25:24:1 (Sigma). 
7. 16mM hydroquinone (Sigma). 
8. 4M NaHSO3 pH 5.0 (sodium bisulfite; Sigma; see Note 1). 
9. 10% SDS. 
10. Proteinase K Buffer: 50mM Tris-HCl pH 8, 100mM EDTA, 100mM NaCl. 
11. Proteinase K (Roche). 
12. RNase A (Roche). 
13. Phase Lock Gel 2ml tubes (Eppendorf). 
14. 2mM dNTPs. 
15. Bisulfite-sequencing or methylation-specific oligonucleotides (see Note 2). 
16. Taq DNA Polymerase of choice (in our case, FastStart Taq DNA Polymerase 
set, Roche, including 10x Taq polymerase buffer and 50 mM MgCl2) 
17. Wizard DNA clean-up kit (Promega).  
18. QIAquick Gel Extraction kit (Qiagen). 
19. QIAGEN Plasmid Mini kit (Qiagen). 
20. pGEM-TEasy Vector System kit (Promega). 
21. JM109 competent cells. 
22. LB plates with ampicillin/IPTG/X-gal. 
23. DNA 100bp ladder (Invitrogen). 
24. Standard 1xTBE DNA electrophoresis buffer. 
25. For DNA electrophoresis, use 0.8% agarose (Pronadisa) in 1xTBE buffer 
containing 1x SYBR® Safe DNA gel stain (Invitrogen). 
26. DNA electrophoresis equipment 
27. Heating blocks. 
28. Polytron. 
29. Rotator wheel. 
30. Refrigerated tabletop minifuge. 
2.3. Immunodetection of 5mC in epidermal whole-mounts.  
1. 1N HCl (Merck). 
2. 1x Tris-borate-EDTA (TBE) buffer. 
3. Fixation solution: 3.7 % formaldehyde (Merck) in PBS (see Note 3). 
4. Permeabilization and blocking (PTG) buffer solution: 0.5 % Triton X-100 (Sigma), 
0.2% gelatin (Merck) in PBS (see Note 4). 
5. Specific antibodies raised against 5-methyl-cytidine or 5-methyl-cytosine (see 
Note 5)  
6. Mounting medium: Vectashield (Vector Labs)-DAPI (Sigma) (see Note 6).  
7. Leica TCS SP2 or SP5 AOBS Laser Scanning Spectral Confocal Microscopes.  
8. Image acquisition software: Leica Confocal Software (LCS) Lite and Leica 
Application Suite Advanced Fluorescence (LAS AF) Suite 2.6.1 (Leica). 
http://www.csc.mrc.ac.uk/microscopy/links.html 
9. Image processing and quantification software: Fiji. http://fiji.sc/Fiji 
3. Methods 
3.1. Isolation of epidermis from mouse tail skin 
This procedure essentially follows the guidelines stated by Braun et al. [15]. 
1. Sacrifice the mice following the guidelines of the corresponding housing animal 
facility, cut the tail and peel the skin in a whole piece from the tail backbone. 
2. Incubate the peeled tail skin in PBS with 5 mM EDTA at 37 ºC for 4 h. 
3. Separate the epidermis from the dermis using tweezers as a whole sheet of 
tissue. 
3.2. DNA extraction, sodium bisulfite sequencing and methylation-specific PCR 
1. Add 500 µl of Proteinase K Buffer to a 0.5 cm x 0.5 cm piece of fresh or frozen (-
80ºC) epidermal sheet obtained in step 3.1.3 and homogenize the tissue using a 
Polytron. 
2. Add 50 µl of 10% SDS, 50 µl of a 200 mg/ml Proteinase K stock and 20 µg/ml of 
RNase A to the homogenate and incubate overnight at 37ºC on a rotator wheel. 
3. Liquate the jellified homogenate by gently pipetting and transfer the volume to a 
Phase Lock Gel tube. 
4. Add 500 µl of phenol/chloroform/isoamyl alcohol 25:24:1, mix well by inversion 
and incubate 15-30 min in a rotator wheel. 
5. Transfer to Phase Lock Gel tubes, centrifuge at maximum speed for 5 min in a 
tabletop minifuge and transfer the aqueous phase supernatant to a 2ml tube. 
6. Add 50 µl of 3M sodium acetate and 1.5 ml of 100% ethanol, mix well by 
inversion and centrifuge at maximum speed in a tabletop minifuge for 10 min at 4ºC. 
7. Discard the supernatant and wash the DNA pellet two times with 1 ml of 70% 
ethanol, resuspend the pellet in 50-100 µl of sterile water, evaporate the residual 
ethanol content by heating the open tube at 50ºC for 5 min and quantify the DNA 
content. 
8. Add 1 µg of genomic DNA to a final volume of 50 µl of sterile water. 
9. Add 5.7 µl of 3M NaOH to the DNA volume and incubate 10 min at 37ºC. 
10. Add 33 µl of 16mM hydroquinone and 530 µl of 4M NaHSO3 and incubate 6-8 h 
at 50 ºC (see Note 7). 
11. Purify the DNA using the Wizard DNA-Clean up kit following the instructions of 
the manufacturer. 
12. Elute the DNA in 50 µl of sterile water, add 5.7 µl of 3M NaOH and incubate 15 
min at 37ºC. 
13. Precipitate the DNA by adding 1 µl of 10 mg/ml glycogen, 17 µl of 10M AcNH4 
and 450 µl of 100% ethanol. Mix well by inversion and incubate overnight at -80ºC. 
14. Centrifuge at maximum speed in a tabletop minifuge, discard the supernatant 
and wash the DNA pellet two times with 1 ml of 70% ethanol.  Resuspend the pellet in 
50-100 µl of sterile water, evaporate the residual ethanol content by heating the open 
tube at 50ºC for 5 min and quantify the DNA content. 
15. Design methylation-specific nucleotides (see Note 2) and amplify the genomic 
region of interest from bisulfite modified DNA by PCR (see Note 8). 
16. Resolve and separate PCR amplicons by DNA electrophoresis in 0.8% agarose 
gels. Extract and purify PCR amplicons using QIAquick Gel Extraction kit following the 
instructions of the manufacturer. 
17. Clone each PCR amplicon in JM109 competent cells using the pGEM-TEasy 
Vector System as indicated in the instructions of the manufacturer. A typical ligation 
reaction for cell transformation combines 3 µl of purified PCR amplicon, 1 µl of pGEM-T 
vector, 1 µl of T4 ligase and 2.5 µl of reaction buffer. 
18. Plate each transformed clone on LB plates containing ampicillin/IPTG/X-gal 
exactly as described in the manufacturer´s instructions and growth overnight at 37ºC. 
19. After the growth of clearly distinguishable white and blue colonies, pick up at 
least 10 white positive colonies from each individual plate. Inoculate each picked white 
colony into 1,250 ml of ampicillin containing LB medium and growth overnight at 37ºC. 
20. Purify plasmids from each grow colony using QIAGEN Plasmid Mini kit and 
sequence cloned inserts using the method of choice. 
3.3. Immunodetection of 5mC in epidermal whole-mounts.  
1. Fix the whole sheet of epidermal tissue obtained in step 3.1.3 with 3.7 % 
formaldehyde in PBS at 4 ºC for at least 24 h. 
2. Thoroughly wash the tissue with PBS and store at 4 ºC in PBS containing 0.02% 
sodium azide. 
3. Cut fixed epidermal sheets into 0.5 cm x 0.5 cm pieces and incubate the 
epidermal pieces with 1 N HCl for 45 min at 37 ºC to hydrolyse chromatin (see Note 9). 
Wash before and after the incubation with distilled water. 
4. Incubate with 1xTBE for 5 min at room temperature (RT) to neutralize acid 
hydrolysis and thoroughly wash with distilled water. 
5. Permeabilize and block tissue pieces by incubating with PTG buffer for 30 min at 
RT. 
6. Incubate tissue samples with specific antibodies recognizing 5mC (see Note 5) 
diluted 1:50 in PBS overnight at 37 ºC. 
7. Thoroughly wash samples at least three times in PBS and mount in Vectashield-
DAPI on slides facing upwards the inner side of the epidermis. Keep samples in the 
dark at 4 ºC until confocal microscopy analysis. 
4. Notes 
1. Combine 7.5 gr of sodium bisulfite and 20 ml of sterile H20. Adjust solution to pH 
5.0 by adding 500 µl of 10M NaOH. 
2. Two types of oligonucleotides can be used to amplify by PCR a particular 
genomic region in a bisulfite-modified DNA pool: bisulfite-sequencing or methylation 
specific primers.  
Methylation-specific primers are designed to produce a PCR amplicon only if a set 
of CpG nucleotides in the target sequence that are contained in each forward and/or 
reverse oligonucleotide sequence are transformed (CpG-UpG transition; unmethylated) 
or not (CpG-CpG transition; methylated) after sodium bisulfite DNA treatment. This 
Methylation Specific PCR (MSP) can provide a preliminary hint on the CpG methylation 
status of the genomic region of interest. The sequence of these oligonucleotides should 
contain a significant number of informative CpG nucleotides. 
Bisulfite-sequencing primers are designed to amplify the target sequence regardless 
of the CpG-UpG transformation degree after bisulfite treatment inside the amplicon. 
The resulting PCR amplicon is intended for further DNA sequencing and the resulting 
data provide information on the methylation status of all CpGs in the target genomic 
region. The sequence of these oligonucleotides must not contain CpGs. 
Ideally for both types of oligonucleotides, the annealing temperature (Tm) of each 
primer pair should be similar (+/-5ºC) on a 55-65ºC range and the size of the amplicon 
should not exceed 350bp. Different overlapping amplicons can be used to map a 
particular genomic region of interest that is larger than 400bp. There are different 
software packages that help to design both types of oligonucleotides. We can 
recommend Methyl Primer Express software (Applied Biosystems; 
https://products.appliedbiosystems.com/ab/en/US/adirect/ab?cmd=catNavigate2&catID
=602121). 
3. The fixation solution should be kept in a neutral pH range (6.8-7.5). Acidification 
of the solution, which progressively takes place at RT, results in a drastic reduction of 
formaldehyde fixative properties. 
4. For PTG buffer preparation, weight 100 mg of gelatin powder, heat 20 ml of PBS 
at 60 ºC in a glass beaker, slowly pour the gelatin powder into the PBS volume and 
thoroughly stir until the solution reach RT. At this point, complete the PBS volume up to 
50 ml, add 250 µl of Triton X-100 and stir for additional 20 min. 
5. There are several commercially available antibodies raised against 5-mthyl-
cytidine or 5-methyl-cytosine that specifically recognize 5mC on the chromatin fiber or 
on the isolated DNA molecule. Here we have used a non-commercial original batch of 
a mouse monoclonal antibody raised against 5-methyl-cytidine, kindly supplied by A. 
Niveleau [10, 11] 
6. Prepare a DAPI stock solution, 10 mg/ml in distilled water and store at -20 ºC. 
Combine 5 µl of concentrated DAPI stock with distilled water to a final volume of 1 ml, 
obtaining a 50 ng/ml intermediate stock. Add 100 µl of DAPI intermediate stock solution 
to 900 µl of Vectashield, to obtain 1 ml of mounting medium containing DAPI at 5 
ng/ml. Store at 4 ºC in the dark. Samples should be kept in mounting medium a 
minimum of 30 min before microscopy analysis to ensure that minor groove insertion of 
DAPI in the DNA molecule reaches a suitable chemical equilibrium for optimal 
detection. Mounted samples can be stored at -20 ºC in the dark 1-2 weeks showing 
good emission and resolution efficiencies.  
7. Sodium bisulfite induces severe DNA degradation. Longer incubation times (16-
18 h, or overnight) proposed in other protocols can enhance this process. In the same, 
a 4M sodium bisulfite concentration can cause excessive DNA degradation in some 
tissue and cell types. 
8. For amplicons up to 400bp size, guideline standard PCR amplification conditions 
can be as follows:  
Initial denaturing step, 1 cycle, 5 min, 95ºC;  
Amplification step, 35 cycles: 
 Denaturing, 30 sec, 95ºC 
 Annealing, 30 sec at the lower Tm of the primer pair 
 Extension, 30 sec, 72ºC 
Final extension step, 1 cycle, 5 min, 72ºC 
9. Mild acid hydrolysis of chromatin is critical. A short hydrolysis time results in a 
defective nucleotide epitope unmasking, while excessively longer hydrolysis results in 
extensive chromatin degradation. 
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Figure 1.  DNA methylation status of the rDNA gene start promoter region and 
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